MidAmerica Cancer Care, LLC ( Site 0043) — Kansas City, Missouri

MidAmerica Cancer Care, LLC ( Site 0043) is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

MidAmerica Cancer Care, LLC ( Site 0043) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidAmerica Cancer Care, LLC ( Site 0043)?

MidAmerica Cancer Care, LLC ( Site 0043) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidAmerica Cancer Care, LLC ( Site 0043) conducted?

MidAmerica Cancer Care, LLC ( Site 0043) has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is MidAmerica Cancer Care, LLC ( Site 0043) accredited by Crixeo Health?

MidAmerica Cancer Care, LLC ( Site 0043) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidAmerica Cancer Care, LLC ( Site 0043)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.